Approval · Notice of Compliance 902 · 2003
PHL-FENOFIBRATE MICRO: Notice of Compliance 902
Issued April 23, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 902
- Date
- April 23, 2003
- Company
- Pharmel Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHL-FENOFIBRATE MICRO | 02247489 | Cancelled Post Market |
Medicinal ingredients
- FENOFIBRATE 200 MG per CAP